Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Eiger BioPharmaceuticals, Inc. (EIGRQ) had Debt to Equity Ratio of -2.84 for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
$3.80M |
|
$-13.45M |
|
$0.10M |
|
$3.70M |
|
$16.42M |
|
$-12.61M |
|
$-0.84M |
|
$-13.45M |
|
$-13.45M |
|
$-13.45M |
|
$-13.45M |
|
$-13.45M |
|
$-13.45M |
|
$-12.61M |
|
$-12.62M |
|
1.48M |
|
1.48M |
|
$-8.74 |
|
$-8.74 |
|
| Balance Sheet Financials | |
$37.84M |
|
$0.63M |
|
$0.99M |
|
$38.83M |
|
$53.28M |
|
-- |
|
-- |
|
$53.28M |
|
$-14.46M |
|
$-14.46M |
|
$-14.46M |
|
1.48M |
|
| Cash Flow Statement Financials | |
$-74.55M |
|
$74.23M |
|
$0.04M |
|
$25.80M |
|
$25.44M |
|
$-0.36M |
|
$5.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.71 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-2.84 |
97.34% |
|
-331.69% |
|
-331.69% |
|
-- |
|
-353.72% |
|
-353.77% |
|
$-74.78M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.06 |
|
2.26 |
|
39.81 |
|
93.06% |
|
93.06% |
|
-34.65% |
|
93.06% |
|
$-9.78 |
|
$-50.67 |
|
$-50.51 |
|